Biodegradable microspheres in drug delivery
- PMID: 8521523
- DOI: 10.1615/critrevtherdrugcarriersyst.v12.i1.10
Biodegradable microspheres in drug delivery
Abstract
General aspects of biodegradable microspheres prepared from natural and synthesized polymers used in drug delivery systems are reviewed first from various viewpoints: characteristics of biodegradable polymers (physicochemical properties, bioerosion mechanism, biocompatibility), preparation method for the microspheres, drug release from parenteral products and briefly nonparenteral products. The relationship between release pattern and pharmacological activity of therapeutic peptides and proteins and rational controlled release design are also discussed. In the latter half, successful sustained release depot formulations of peptides, leuprorelin acetate, and thyrotropin-releasing hormone (TRH), utilizing poly(lactic acid) (PLA) and poly(lactic/glycolic acid) (PLGA) microspheres are reviewed with respect to preparation, drug release, biocompatibility, pharmacological effects, and results of clinical studies. Thereafter, studies on antitumor therapy by chemoembolization using PLGA microspheres containing an angiogenesis inhibitor (TNP-470) are described as an example of targeted drug delivery with biodegradable microspheres.
Similar articles
-
Preparation of poly-lactic acid microspheres containing the angiogenesis inhibitor TNP-470 with medium-chain triglyceride and the in vitro evaluation of release profiles.Eur J Pharm Biopharm. 2003 Mar;55(2):155-60. doi: 10.1016/s0939-6411(02)00156-x. Eur J Pharm Biopharm. 2003. PMID: 12637091
-
Biodegradable poly (lactic acid) microspheres for drug delivery systems.Yonsei Med J. 2000 Dec;41(6):720-34. doi: 10.3349/ymj.2000.41.6.720. Yonsei Med J. 2000. PMID: 11204823 Review.
-
Clinical pharmacokinetics of depot leuprorelin.Clin Pharmacokinet. 2002;41(7):485-504. doi: 10.2165/00003088-200241070-00003. Clin Pharmacokinet. 2002. PMID: 12083977 Review.
-
Application of a spray drying technique in the production of TRH-containing injectable sustained-release microparticles of biodegradable polymers.PDA J Pharm Sci Technol. 1995 Jul-Aug;49(4):180-4. PDA J Pharm Sci Technol. 1995. PMID: 7552237
-
Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.Pharm Res. 1994 Aug;11(8):1143-7. doi: 10.1023/a:1018936815654. Pharm Res. 1994. PMID: 7971715
Cited by
-
Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model.Front Immunol. 2015 Jun 2;6:273. doi: 10.3389/fimmu.2015.00273. eCollection 2015. Front Immunol. 2015. PMID: 26082781 Free PMC article.
-
Versatility of Particulate Carriers: Development of Pharmacodynamically Optimized Drug-Loaded Microparticles for Treatment of Peritoneal Cancer.AAPS J. 2015 Sep;17(5):1065-79. doi: 10.1208/s12248-015-9785-x. Epub 2015 Jun 19. AAPS J. 2015. PMID: 26089090 Free PMC article. Review.
-
A New Approach to Supramolecular Structure Determination in Pharmaceutical Preparation of Self-Assembling Peptides: A Case Study of Lanreotide Autogel.Pharmaceutics. 2022 Mar 20;14(3):681. doi: 10.3390/pharmaceutics14030681. Pharmaceutics. 2022. PMID: 35336055 Free PMC article.
-
Formulation, characterization and evaluation of the effect of polymer concentration on the release behavior of insulin-loaded Eudragit(®)-entrapped mucoadhesive microspheres.Int J Pharm Investig. 2016 Apr-Jun;6(2):69-77. doi: 10.4103/2230-973X.177806. Int J Pharm Investig. 2016. PMID: 27051626 Free PMC article.
-
Mathematical modelling of the evolution of protein distribution within single PLGA microspheres: prediction of local concentration profiles and release kinetics.J Mater Sci Mater Med. 2008 Apr;19(4):1587-93. doi: 10.1007/s10856-007-3301-5. Epub 2007 Nov 8. J Mater Sci Mater Med. 2008. PMID: 17992472
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources